Protein idea sold to Swiss pharmaceutical giant Roche.
ProteoPharma has developed a protein that can remove deposited cholesterol from the blood vessels and can potentially evolve into a new super drug that can act as a sort of ‘drainage’ in the calcified veins of the heart – both for effective acute treatment and possible blood clot prevention.
Professor Søren Moestrup at the Department of Medical Biochemistry at the University of Aarhus founded the company in 2000. CAPNOVA was an investor from the very beginning.
In 2004, ProteoPharma’s protein idea was sold to the Aarhus based company Borean Pharma, which had both the means and the manufacturing technology to carry the idea even further.
In 2006, the protein idea was sold to the Swiss pharmaceutical giant Roche. ProteoPharma was officially dissolved in 2007, and it was at this time that CAPNOVA left the company.
Atherosclerosis is the most frequent cause of death in Denmark, and there is therefore great potential, both socially and commercially, in developing more effective medicine in this area.
Have a look at some of our other companies
Read more about some of our other companies that are on their way to the top and others that have already made it.
Our current companies
Explore our entire portfolio
Companies that went all the way